Gland Pharma Ltd (GLAD)

BSE
Currency in INR
1,689.30
+22.65(+1.36%)
Closed·
GLAD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GLAD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,621.001,692.20
52 wk Range
1,200.002,220.95
Key Statistics
Edit
Bid/Ask
1,687.70 / 1,689.30
Prev. Close
1,666.65
Open
1,621
Day's Range
1,621-1,692.2
52 wk Range
1,200-2,220.95
Volume
1.56K
Average Volume (3m)
13.59K
1-Year Change
-8.98%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLAD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Gland Pharma Ltd News & Analysis

Show more

Gland Pharma Ltd Company Profile

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Employees
4286
Market
India

Compare GLAD to Peers and Sector

Metrics to compare
GLAD
Peers
Sector
Relationship
P/E Ratio
39.8x33.1x−0.5x
PEG Ratio
−4.170.930.00
Price/Book
3.0x5.0x2.6x
Price / LTM Sales
4.9x4.4x3.1x
Upside (Analyst Target)
−6.8%13.3%50.4%
Fair Value Upside
Unlock−3.1%8.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 42.40%
Dividend Yield
1.07%
Industry Median 0.69%
Annualised payout
18.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 20, 2025
EPS / Forecast
11.30 / 16.10
Revenue / Forecast
14.25B / 16.46B
EPS Revisions
Last 90 days

GLAD Income Statement

FAQ

What Is the Gland Pharma Ltd (GLAD) Stock Price Today?

The Gland Pharma Ltd stock price today is 1,689.30.

What Stock Exchange Does Gland Pharma Ltd Trade On?

Gland Pharma Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Gland Pharma Ltd?

The stock symbol for Gland Pharma Ltd is "GLAD."

Does Gland Pharma Ltd Pay Dividends? What’s The Current Dividend Yield?

The Gland Pharma Ltd dividend yield is 1.07%.

What Is the Gland Pharma Ltd Market Cap?

As of today, Gland Pharma Ltd market cap is 278.39B.

What Is Gland Pharma Ltd's Earnings Per Share (TTM)?

The Gland Pharma Ltd EPS (TTM) is 42.40.

When Is the Next Gland Pharma Ltd Earnings Date?

Gland Pharma Ltd will release its next earnings report on 15 Jul 2025.

From a Technical Analysis Perspective, Is GLAD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Gland Pharma Ltd Stock Split?

Gland Pharma Ltd has split 0 times.

How Many Employees Does Gland Pharma Ltd Have?

Gland Pharma Ltd has 4286 employees.

What is the current trading status of Gland Pharma Ltd (GLAD)?

As of 13 Jun 2025, Gland Pharma Ltd (GLAD) is trading at a price of 1,689.30, with a previous close of 1,666.65. The stock has fluctuated within a day range of 1,621.00 to 1,692.20, while its 52-week range spans from 1,200.00 to 2,220.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.